Management and Diagnostic Approach for Hematuria
All patients with gross hematuria should be referred for urologic evaluation, even if self-limited, while patients with microscopic hematuria require risk-stratified evaluation based on patient factors and the absence of demonstrable benign causes. 1
Initial Evaluation
Confirming Hematuria
- Confirm heme-positive dipstick results with microscopic urinalysis showing ≥3 erythrocytes per high-powered field before initiating further evaluation 1
- Always ask patients with microscopic hematuria about any history of gross hematuria, as this significantly increases cancer risk (OR 7.2) 2
- Pursue evaluation of hematuria even if the patient is receiving antiplatelet or anticoagulant therapy 1
Initial Laboratory Workup
- Complete urinalysis with microscopic examination to assess:
- RBC morphology (dysmorphic RBCs suggest glomerular source)
- Presence of casts, crystals, or pyuria
- Proteinuria (suggests possible glomerular pathology) 2
- Complete metabolic panel to assess renal function
- Urine culture to rule out infection
- Urine cytology 2
Risk Stratification
High-Risk Features for Urologic Malignancy
- Gross hematuria (>10% risk of urologic cancer) 3
- Age >40 years (higher risk if >60 years)
- Smoking history
- Male gender
- Occupational exposure to chemicals or dyes
- Previous urologic disorders 2
Features Suggesting Glomerular Pathology
- Dysmorphic RBCs
- Red cell casts
- Significant proteinuria
- Reduced eGFR (<60 ml/min/1.73m²)
- Systemic symptoms 2
Diagnostic Algorithm
For Gross Hematuria
- Immediate urologic referral is mandatory 1, 3
- Imaging of the upper urinary tract:
- Cystoscopy to evaluate the bladder and urethra 4
- Consider concurrent nephrology referral if signs of glomerular disease are present 2
For Microscopic Hematuria
- Evaluate for benign causes:
- Urinary tract infection
- Benign prostatic hyperplasia
- Urinary calculi 3
- If no benign cause is identified:
- For patients with features suggesting glomerular disease, consider nephrology referral 2
Imaging Recommendations
- CT urography: First-line for most patients with hematuria requiring imaging 2
- Ultrasound: Consider for younger patients (lower radiation risk) or as initial screening, though sensitivity is lower (50%) 2
- MR urography: Alternative for patients with contraindications to CT 2
Common Pitfalls to Avoid
Dismissing hematuria in patients on anticoagulants: Anticoagulation may unmask underlying pathology but is rarely the sole cause of hematuria 1
Assuming bright red rectal bleeding is from a distal source: May represent brisk upper GI bleeding in up to 11% of cases 2
Failing to ask about history of gross hematuria: Even self-limited episodes significantly increase cancer risk 2
Using urinary cytology or other urine-based molecular markers in initial evaluation: Not recommended by guidelines 1
Screening asymptomatic adults with urinalysis: Not recommended for cancer detection 1
Follow-up and Surveillance
- Patients with persistent hematuria require continued surveillance
- Repeat urinalysis within 12 months
- New symptoms, gross hematuria, or increased degree of microscopic hematuria should prompt immediate re-evaluation 2
Special Considerations
- In children, consider recent infections, exercise-induced hematuria, and rare conditions like Alport syndrome 2, 5
- Drug-induced hematuria, especially from analgesics, needs to be recognized in routine clinical practice 5
- Shock index (heart rate/systolic BP) >1 suggests significant bleeding requiring urgent evaluation 2